Cargando…
LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective
Inactivating mutations of the tumor suppressor gene Liver Kinase B1 (LKB1) are frequently detected in non-small-cell lung cancer (NSCLC) and cervical carcinoma. Moreover, LKB1 expression is epigenetically regulated in several tumor types. LKB1 has an established function in the control of cell metab...
Autores principales: | Ciccarese, Francesco, Zulato, Elisabetta, Indraccolo, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6874879/ https://www.ncbi.nlm.nih.gov/pubmed/31781355 http://dx.doi.org/10.1155/2019/8730816 |
Ejemplares similares
-
LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer
por: Bonanno, Laura, et al.
Publicado: (2019) -
Involvement of NADPH Oxidase 1 in Liver Kinase B1-Mediated Effects on Tumor Angiogenesis and Growth
por: Zulato, Elisabetta, et al.
Publicado: (2018) -
AMPK potentiation by LKB1 isoforms
por: Thibert, Chantal, et al.
Publicado: (2015) -
LKB1 and AMPK and the cancer-metabolism link - ten years after
por: Hardie, D Grahame, et al.
Publicado: (2013) -
Connecting LKB1 and AMPK links metabolism with cancer
por: Moore, Pete
Publicado: (2003)